Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Total 13F shares
-
30,100,794
-
Share change
-
-1,454,827
-
Total reported value
-
$3,243,258,025
-
Put/Call ratio
-
140%
-
Price per share
-
$107.74
-
Number of holders
-
264
-
Value change
-
-$145,765,900
-
Number of buys
-
150
-
Number of sells
-
112
Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q3 2025
As of 30 Sep 2025,
GeneDx Holdings Corp. - Common Stock (WGS) was held by
264 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,100,794 shares.
The largest 10 holders included
Corvex Management LP, Casdin Capital, LLC, BlackRock, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, ORACLE INVESTMENT MANAGEMENT INC, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, T. Rowe Price Investment Management, Inc., and FRANKLIN RESOURCES INC.
This page lists
264
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.